OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 29
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights
Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106799-106799
Closed Access | Times Cited: 23
Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106799-106799
Closed Access | Times Cited: 23
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
B. Kumaraswamy, K. Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116561-116561
Closed Access | Times Cited: 7
B. Kumaraswamy, K. Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116561-116561
Closed Access | Times Cited: 7
Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 6
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 6
Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Journal of Molecular Structure (2025) Vol. 1327, pp. 141227-141227
Closed Access
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Journal of Molecular Structure (2025) Vol. 1327, pp. 141227-141227
Closed Access
Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108106-108106
Closed Access
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108106-108106
Closed Access
Green one-pot synthesis of quinoxaline derivatives using sulfo-anthranilic acid functionalized alginate-MCFe2O4 nanostructures: a novel superparamagnetic catalyst with antiproliferative potential
Ying Lai, Ruoyu Zhang
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1698-1712
Open Access
Ying Lai, Ruoyu Zhang
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1698-1712
Open Access
Thiazolidinedione derivatives: emerging role in cancer therapy
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 14
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 14
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Evaluation of Novel Spiro-pyrrolopyridazine Derivatives as Anticancer Compounds: In Vitro Selective Cytotoxicity, Induction of Apoptosis, EGFR Inhibitory Activity, and Molecular Docking Analysis
Harika Atmaca, Süleyman İlhan, Çisil Çamlı Pulat, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23713-23723
Open Access | Times Cited: 4
Harika Atmaca, Süleyman İlhan, Çisil Çamlı Pulat, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23713-23723
Open Access | Times Cited: 4
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Novel Pyrazole‐Chalcone Hybrids: Synthesis and Computational Insights Against Breast Cancer
Pratap S. Dabhade, Manjushri P. Dabhade, Lala S. Rathod, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 7
Closed Access | Times Cited: 1
Pratap S. Dabhade, Manjushri P. Dabhade, Lala S. Rathod, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 7
Closed Access | Times Cited: 1
Elucidating bis-pyrimidines as new and efficient mushroom tyrosinase inhibitors: synthesis, SAR, kinetics and computational studies
Manazza Afzal, Rabia Mehmood, Ehsan Ullah Mughal, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22769-22780
Open Access | Times Cited: 1
Manazza Afzal, Rabia Mehmood, Ehsan Ullah Mughal, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22769-22780
Open Access | Times Cited: 1
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 1
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 1
Synthesis, fluorescence, enzymes effects, and evaluation of tetrahydroxy substituted zinc phthalocyanine as multitarget metabolic enzyme inhibitors with molecular docking: the biochemistry-oriented drug design
Derya Güngördü Solğun, Nastaran Sadeghian, Tuğba Taşkın‐Tok, et al.
Journal of the Iranian Chemical Society (2024) Vol. 21, Iss. 9, pp. 2413-2424
Closed Access | Times Cited: 1
Derya Güngördü Solğun, Nastaran Sadeghian, Tuğba Taşkın‐Tok, et al.
Journal of the Iranian Chemical Society (2024) Vol. 21, Iss. 9, pp. 2413-2424
Closed Access | Times Cited: 1
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 1
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 1
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108011-108011
Closed Access | Times Cited: 1
New 8-Heterocyclic Xanthine Derivatives as Antiproliferative Agents: Synthesis and Biological Evaluation
Bilgesu Onur Sucu
Journal of the Turkish Chemical Society Section A Chemistry (2024) Vol. 11, Iss. 2, pp. 533-540
Open Access
Bilgesu Onur Sucu
Journal of the Turkish Chemical Society Section A Chemistry (2024) Vol. 11, Iss. 2, pp. 533-540
Open Access
Exploring of a Potential Breast Cancer Based on Isoxazole Derivatives: An Integrated In-Silico Methods
Youness Moukhliss, Yassine Koubi, Marwa Alaqarbeh, et al.
(2024)
Closed Access
Youness Moukhliss, Yassine Koubi, Marwa Alaqarbeh, et al.
(2024)
Closed Access
